Nolxado (Naloxone Hydrochloride, Oxycodone Hydrochloride)

Naloxone Hydrochloride, the active ingredient in Nolxado, is an opioid analgesic combination presented as an oral tablet for oral use. It is indicated for the management of moderate to severe pain and incorporates an opioid antagonist to reduce abuse potential.

GNH USA supplies Nolxado as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nolxado, a combination opioid analgesic, is used to manage pain that involves the mu‑opioid receptor pathway.

- Moderate to severe acute pain: provides effective analgesia while limiting opioid‑related abuse risk. - Post‑operative pain: controls pain following surgical procedures. - Chronic cancer pain: offers sustained relief for patients requiring opioid therapy.

Nolxado may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel movements. - Dizziness: sensation of light‑headedness. - Drowsiness: increased sleepiness. - Dry mouth: reduced salivation. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Hepatic dysfunction: abnormal liver enzymes or jaundice. - Seizures: rare convulsive episodes. - Opioid withdrawal: signs of dependence reversal when misused.

Before prescribing Nolxado, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Assess pain severity: ensure opioid therapy is appropriate for the level of pain. - Monitor for dependence: watch for signs of opioid misuse or addiction. - Avoid in severe respiratory depression: the drug can exacerbate breathing difficulties. - Use caution in hepatic impairment: metabolism may be altered. - Avoid concomitant CNS depressants: increased risk of sedation and respiratory effects. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Nolxado can interact with other medications; some combinations require avoidance while others need close monitoring.

Major Interactions (Avoid): - Other strong opioids: additive risk of respiratory depression. - Benzodiazepines or barbiturates: heightened central nervous system depression. - Monoamine oxidase inhibitors (MAOIs): potential for hypertensive crisis.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase oxycodone plasma levels. - CYP3A4 inducers (e.g., rifampin): may reduce analgesic efficacy. - Anticholinergic agents: can worsen constipation associated with opioid use.